BioNTech says vaccine ‘neutralises’ key mutation in UK, S.Africa strains
German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than the original COVID-19 strain.